Biotech
AI & ML
Vivan Therapeutics begins AI oncology trial at Abu Dhabi cancer centre
Hub71-backed Vivan Therapeutics launches a UAE clinical study for its genomics-matched cancer decision tool, generating the Gulf's first reimbursement evidence.
Hub71-backed Vivan Therapeutics launches a UAE clinical study for its genomics-matched cancer decision tool, generating the Gulf's first reimbursement evidence.